BSC-1非洲綠猴腎細(xì)胞（附S 返回列表頁

舉報(bào) 評(píng)價(jià)

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品牌

廠商性質(zhì)生產(chǎn)商

所在地

在線詢價(jià) 加入對(duì)比查看聯(lián)系電話

更新時(shí)間：2025-02-11 20:19:18瀏覽次數(shù)：6次

聯(lián)系我時(shí)，請(qǐng)告知來自化工儀器網(wǎng)

同類優(yōu)質(zhì)產(chǎn)品更多>

HTMC人眼小梁網(wǎng)細(xì)胞（附ST

參考價(jià) 面議
ECC-1人子宮內(nèi)膜癌細(xì)胞（附

參考價(jià) 面議
MOVAS小鼠主動(dòng)脈平滑肌細(xì)胞

參考價(jià) 面議
LEC-1倉鼠卵巢細(xì)胞、LEC

參考價(jià) 面議
H4 人神經(jīng)膠質(zhì)瘤細(xì)胞、H4

參考價(jià) 面議

產(chǎn)品分類品牌分類

細(xì)胞庫 / 細(xì)胞培養(yǎng): 細(xì)胞株 ATCC細(xì)胞原代細(xì)胞干細(xì)胞普通細(xì)胞

全部產(chǎn)品列表

產(chǎn)品簡(jiǎn)介

BSC-1非洲綠猴腎細(xì)胞CatalogueNo

詳情介紹

BSC-1 非洲綠猴腎細(xì)胞
Catalogue No.: C272
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%EMEM(MEM+NEAA)+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

Item	Specifications
a T25 flask	2X10⁶
Manual	1 copy

(pembrolizumab) showed limited antitumor activity with an objective response rate (ORR) of 3.7% in 107 patients with advanced well-differentiated neuroendocrine tumors (NET) (6). The multicohort, phase 1 KEYNOTE-028 study in patients with PD-L1-positive NET treated with pembrolizumab demonstrated an ORR of 12.0% inpatients with carcinoid and 6.3% in patients with well-differentiated or moderately-differentiated pancreatic NET (7). In addition, based on a phase II basket trial of anti-CTLA-4 (ipilimumab) and anti-PD-1 (nivolumab)